Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children

• المؤلفون الرئيسيون: Phongsamart W., Sirisanthana V., Wittawatmongkol O., Maleesatharn A., Sudjaritruk T., Chearskul P., Aurpibul L., Sirisanthana T., Chokephaibulkit K.
• التنسيق: مقال
• اللغة: English
• منشور في: 2014
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?eid=2-s2.0-82455192719&partnerID=40&md5=78078c78735aee2d0fe08d311fee9c6c; http://cmuir.cmu.ac.th/handle/6653943832/3710

To evaluate the immunogenicity and safety of the monovalent pandemic influenza A (H1N1) 2009 (pH1N1) vaccine in HIV-infected Thai children, 2 doses, 28days apart, of non-adjuvant monovalent pH1N1 vaccine (Panenza® by Sanofi Pasteur, 15μg/dose) provided by the National Health Promotion Program of the...